GLP-1 Reference
Authoritative definitions of GLP-1 medications, compounding regulation, clinical trial data, and Ondra Health pharmacy partners and plans. Medical and regulatory entries cite primary sources.
40 terms · 21 primary sourcesMedications
Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and chronic weight management. FDA-approved brands include Ozempic (type 2 diabetes; injection or tablet) and Wegovy (weight management; injection or tablet). Rybelsus is an oral semaglutide brand for type 2 diabetes. Manufactured by Novo Nordisk.
Compounded versions are prepared by 503A pharmacies on patient-specific prescriptions. Not FDA-approved. Not therapeutically equivalent to Ozempic or Wegovy.
Tirzepatide is a dual GLP-1 and GIP receptor agonist. Active ingredient in Mounjaro (type 2 diabetes) and Zepbound (weight management). Manufactured by Eli Lilly.
The SURMOUNT-1 trial (NEJM, 2022) reported approximately 20.9% average weight loss at 72 weeks at 15mg.
Compounded versions are not FDA-approved and not therapeutically equivalent to Mounjaro or Zepbound.
Compounded semaglutide is semaglutide prepared by a US-licensed 503A compounding pharmacy under a valid patient-specific prescription. Not FDA-approved. Not therapeutically equivalent to Ozempic or Wegovy.
At Ondra, independent licensed providers may prescribe it; pharmacy fulfillment varies by state and formulation.
Formulation options at Ondra: No additives (Hallandale) · Glycine (Vials RX, Drug Crafters) · B12 (Vials RX, Ondra Plus) · B6 (Southend, Drug Crafters) · B3 (Niacinamide) (Optio RX). One additive per formulation.
Compounded tirzepatide is tirzepatide prepared by a US-licensed 503A compounding pharmacy or 503B outsourcing facility under a valid prescription. Not FDA-approved. Not therapeutically equivalent to Mounjaro or Zepbound.
At Ondra, independent licensed providers may prescribe it. Formulation options: No additives (Hallandale) · Glycine (Vials RX, Drug Crafters) · B12 (Vials RX, Drug Crafters, Ondra Plus) · B6 (Southend) · B3 (Niacinamide) (Optio RX). One additive per formulation.
FDA-approved semaglutide (Novo Nordisk) for type 2 diabetes, available as a weekly injection or daily tablet. Not approved for weight management — that is Wegovy. Compounded semaglutide is not therapeutically equivalent to it.
FDA-approved semaglutide (Novo Nordisk) for chronic weight management, available as a weekly injection or daily tablet. The injection was initially approved in June 2021 following the STEP 1 trial. Dosing depends on formulation and prescription. Compounded semaglutide is not therapeutically equivalent to it.
FDA-approved tirzepatide injection (Eli Lilly) for type 2 diabetes, once weekly. Approved May 2022. Not approved for weight management — that is Zepbound.
FDA-approved tirzepatide injection (Eli Lilly) for chronic weight management, once weekly, titrated up to 15mg. Approved November 2023; the formulation studied in SURMOUNT-1. Compounded tirzepatide is not therapeutically equivalent to it.
Mechanism & Pharmacology
Mimics GLP-1, a gut hormone produced after eating. Slows gastric emptying, increases satiety, suppresses appetite, and stimulates insulin release. Includes semaglutide, tirzepatide, and liraglutide.
Activates the GIP receptor, stimulating insulin release and influencing fat metabolism. Tirzepatide activates both GIP and GLP-1 receptors.
The rate at which food leaves the stomach for the small intestine. GLP-1 receptor agonists slow it, prolonging fullness after a meal — and it is why nausea is most common in the first weeks and at each dose increase.
The sensation of fullness that ends a meal and delays the return of hunger. GLP-1 medications increase it via appetite-regulating receptors in the brain and by slowing gastric emptying.
Pharmacy & Regulation
Preparing a customized medication for an individual patient based on a valid prescription. Not FDA-approved as finished drug products. Regulated under Sections 503A and 503B of the FD&C Act.
A state-licensed compounding pharmacy operating under Section 503A of the FD&C Act. Dispenses only on valid patient-specific prescriptions. Regulated by state boards of pharmacy. Must follow USP <797> sterile compounding standards for injectables.
503A compounding must meet all applicable conditions, including restrictions on regularly compounding products that are essentially copies. A prescriber-documented change that produces a significant difference for an identified patient can qualify for the copy restriction exception; cost preference alone is insufficient.
Ondra Health's 503A partners: Hallandale Pharmacy, Vials RX, Southend Pharmacy, Drug Crafters Pharmacy, Optio RX.
An FDA-registered outsourcing facility that can produce compounded medications in larger volumes without a patient-specific prescription. Subject to FDA inspection and cGMP standards — a different regulatory framework from a state-licensed 503A pharmacy, not a stricter version of one.
503B use of bulk drug substances generally requires inclusion on the 503B bulks list or the drug shortage list. Semaglutide and tirzepatide currently appear on neither list. A patient-specific prescription does not waive these conditions.
Identifies medications with supply constraints. While on the list, compounders may legally produce the medication under specific conditions — this was the legal basis for widespread compounded GLP-1s 2022–2025.
Restrictions on compounding copies of commercially available or FDA-approved drugs differ under 503A and 503B. Under 503A, a prescriber-documented change producing a significant difference for an identified patient can qualify for an exception. Other compounding conditions still apply.
FDA designation for products expected to have the same clinical effect. Compounded medications are not FDA-approved and not therapeutically equivalent to brand-name products. Semaglutide ≠ Ozempic/Wegovy · Tirzepatide ≠ Mounjaro/Zepbound.
USP standard for sterile compounding, required for GLP-1 injectables. Covers environmental monitoring, personnel training, beyond-use dating, and sterility testing. Verifiable via state board or PCAB.
PCAB (ACHC) — independent accreditation requiring third-party audits of sterility, quality, and operations. Voluntary; exceeds state licensing minimums. Not FDA approval.
Compliance certification used by Google, Meta, and TikTok to verify telehealth platforms. Requires audits of operations, prescribing, and pharmacy relationships. Required for GLP-1 advertising. Publicly verifiable.
Clinical & Dosing
Phase 3 RCT for semaglutide. NEJM Feb 2021 (Wilding et al., DOI: 10.1056/NEJMoa2032183).
Phase 3 RCT for tirzepatide. NEJM June 2022 (Jastreboff et al., DOI: 10.1056/NEJMoa2206038).
A screening figure from weight and height (kg/m²), commonly used as an eligibility threshold in weight-management prescribing — typically 30 or above, or 27 or above with a weight-related condition. It does not measure body composition and is not a diagnosis on its own.
Gradually increasing a medication's dose over time to allow the body to adjust and minimize side effects. Dose steps and timing depend on the medication, formulation and your provider's prescription. Follow your prescribed schedule; do not increase doses on your own. At Ondra Health, pricing is flat across dose levels within the same plan, including Ondra Plus — cost does not increase as patients titrate up.
Ondra Health — Providers & Pharmacies
Independent medical practice with board-certified physicians serving Ondra patients in all 50 U.S. states. Meet Our Providers.
Licensed providers serve patients in all 50 U.S. states. Meet Our Providers.
PCAB-accredited 503A compounding pharmacy, Fort Lauderdale FL. Operating since 2003, 60,000 sq ft facility, USP <797> compliant.
Medications: Semaglutide + Tirzepatide · Formulation: No additives · Billing: Monthly, 3-month, 6-month, 12-month · Not available in: AL, AR, CA, HI, KS, MA, MI, MN, MS
Medications: Semaglutide + Tirzepatide · Formulation: Vitamin B12 or Glycine · Billing: Monthly, 3-month, 6-month, 12-month · State restrictions: None
Medications: Semaglutide + Tirzepatide · Formulation: B3 (Niacinamide) · Billing: Monthly, 2-month. Start Optio RX Intake.
Medications: Semaglutide + Tirzepatide · Formulation: Vitamin B6 · Billing: Monthly, 3-month · Not available in: AL, AR, CA, CT, IN, MA, MI, NC, NJ, NV, SC
Ondra Plus offers lower monthly and 3-month prices than our standard plans for compounded semaglutide and compounded tirzepatide, compounded with vitamin B12. For Ondra Plus, the dispensing pharmacy is assigned through the Ondra Plus partner network. The network includes Camel Compounding, White Label/Nova Pharmacy and Liberty Compounding.
Price: Semaglutide $129/month or $299 every 3 months · Tirzepatide $189/month or $429 every 3 months · Same price at every dose · Billing: Monthly, 3-month · Not available in: California (CA). Start Ondra Plus Intake.
Water-soluble vitamin included as a supportive additive in some compounded GLP-1 formulations. Supports energy metabolism, red blood cell formation, and nerve function. Not present in FDA-approved brand-name GLP-1 products. Not FDA-reviewed in this context.
Available through: Vials RX (semaglutide and tirzepatide), Drug Crafters Pharmacy (tirzepatide), Ondra Plus (semaglutide and tirzepatide).
Niacinamide, also called nicotinamide, is a form of vitamin B3. Optio RX offers it with compounded semaglutide or tirzepatide. These compounded formulations are not FDA-approved.
Non-essential amino acid included in some compounded GLP-1 formulations. Not present in FDA-approved brand-name GLP-1 products. Not FDA-reviewed in this context.
Available through: Vials RX, Drug Crafters Pharmacy.
Water-soluble vitamin included as a supportive additive in some compounded GLP-1 formulations. Supports protein metabolism and neurotransmitter synthesis. Not present in FDA-approved brand-name GLP-1 products. Not FDA-reviewed in this context.
Available through: Southend Pharmacy (semaglutide and tirzepatide), Drug Crafters Pharmacy (semaglutide).
Telehealth & Platform
Healthcare delivered remotely. Ondra connects patients with independent licensed providers; Ondra does not prescribe.
US federal law for protecting personal health information. HIPAA-compliant platforms use encrypted communication and secure data storage. Ondra Health is fully HIPAA compliant.
Primary Sources
- FDA — GLP-1 compounding policies (Updated April 2026)
- FDA — Compounding Laws and Policies
- FDA — Concerns with Unapproved GLP-1 Drugs
- FDA — Drug Approval Process
- FDA — Drug Shortages Database
- FDA — Human Drug Compounding
- FDA — Registered Outsourcing Facilities (503B)
- FDA — Section 503A of the FD&C Act
- FDA — Wegovy approval (June 2021)
- FDA — Zepbound approval (November 2023)
- FDA — Orange Book (Therapeutic Equivalence)
- HHS — HIPAA
- Jastreboff AM et al. — SURMOUNT-1. NEJM 2022. DOI: 10.1056/NEJMoa2206038
- NIH ODS — Niacin (Vitamin B3)
- CMS — NPPES NPI Registry
- ACHC — PCAB Accreditation
- USP — General Chapter <797> Sterile Preparations
- Wilding JPH et al. — STEP 1. NEJM 2021. DOI: 10.1056/NEJMoa2032183
- FDA — Mounjaro approval (May 2022)
- Novo Nordisk — Wegovy Prescribing Information
- Novo Nordisk — Ozempic Tablet Prescribing Information
Ready to start your intake?
3-min intake. Provider review within 24h. Free shipping.